What You Should Know
Acomplia is a weight loss drug, which was released in the United Kingdom in 2006. It was only available through a prescription until it was released for over the counter sales. This weight loss drug is designed to only be taken by those who have a Body Mass Index of more than 30 or a Body Mass Index of 27 or higher with health risks such as diabetes or high blood pressure. Acomplia is also known as SR141716, Bethin, Monaslim, Remonabent, Riobant, Slimona, Rimoslim, Zimulti, Riomont and Rimonabant. The makers of Acomplia, Sanofi-Aventis, is a French Pharmaceutical company. Acomplia has not been cleared for sales in the United States although they had been in the process before negative studies came out and the FDA discontinued its approval process. There have been serious complications associated with Acomplia and has been discontinued in many of the countries it was once available in.
There is not an ingredients list located on the official Sanofi-Aventis website for Acomplia. There is mention on third party website of Acomplia containing ingredients similar to THC. It is also thought that Acomplia affects the central nervous system, which is the cause of many of the serious side effects of Acomplia.
Acomplia is used as a weight loss medication for those who are obese. It is not intended for casual weight loss, but for those who have serious obesity issues. The risks associated with Acomplia are considered more serious than the benefits and therefore is not recommended for use anymore. Acomplia is difficult to find and may only be available through prescription in European countries. It is not available in the United States or the United Kingdom at the time of this review. The side effects associated with Acomplia include increased depression and suicide in those taking this medication. There has also been clinical trials proving the onset of such diseases as Multiple sclerosis, Alzheimer’s disease, Amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and Huntington’s disease in those who have a precursor for these diseases. The clinical trials preformed by the makers of Acomplia down played the results. It was not until the drug was released and independent studies were done to show these serious side effects were more prevalent than let on by the drug’s maker.
- Acomplia may be able to help those with weight problems.
- Acomplia may be able to help people stop smoking.
- There is not an official website for Acomplia.
- Acomplia has been discontinued for use in several countries due to serious complications.
- This drug may only be available by prescription.
The side effects for Acomplia have made it a serious risk for users. There has been shown to be an increase in depression and suicides associated with those taking Acomplia. There are also serious neurological disorders which have been associated with the use of Acomplia. Those looking to lose weight should consider a safer weight loss supplement.